Stimulus Leaves Opening For Drug Pricing Deal During Lame Duck

By John Wilkerson / March 24, 2020 at 5:22 PM
A draft of the compromise stimulus bill calls for running health care extenders through November, which would give lawmakers one last Hail Mary attempt to pass drug pricing reforms during the lame duck session of Congress. Both the House Democrat and Senate GOP stimulus bills called for renewing a group of Medicare and Medicaid policies and programs, called extenders, but the Senate’s bill would fund them through fiscal 2021 and the House proposed to fund most of them through November...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.